(Q44805348)

6 December 2017

title

Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). (English)

1 reference

6 December 2017

author

Jonathan Nguyen Van-Tam

series ordinal

4

1 reference

6 December 2017

5

1 reference

6 December 2017

7

Arnold S Monto

1 reference

6 December 2017

Bruno Lina

3

0 references

Martin Schutten

series ordinal

6

object named as

Martin Schutten

1 reference

6 December 2017

Richard J Whitley

1

1 reference

6 December 2017

Charles A Boucher

series ordinal

2

1 reference

6 December 2017

language of work or name

English

0 references

publication date

10 January 2013

1 reference

Clinical Infectious Diseases

6 December 2017

published in

1 reference

6 December 2017

volume

56

1 reference

6 December 2017

issue

9

1 reference

6 December 2017

page(s)

1197-1205

1 reference

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Oral oseltamivir treatment of influenza in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

The ins and outs of universal childhood influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS1220

21 January 2018

Identifiers

DOI

10.1093/CID/CIS1220

1 reference

6 December 2017

1 reference